1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 05 JANUARY 2015

Cancer Drug News 05 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - Keytruda And Opdivo Go Head To Head In Increasingly Competitive Market
Industry Brief - Sacituzumab Govitecan Gains FDA Fast Track Designation For TNBC
Industry Trend Analysis - In Vitro Diagnostics Market Grows As Utility Widens
Industry Brief - Angelini To Commercialise ARIAD's Iclusig In Central/Eastern Europe
Industry Brief - Otsuka To Commercialise ARIAD's Iclusig In Asian Countries
Industry Brief - Spectrum Seeks FDA Approval For Captisol-Enabled Melphalan
Industry Brief - MacroGenics/Janssen Sign MGD011 Licensing Deal For Multiple B-Cell Malignancies
Industry Brief - FDA Approves Gazyva sBLA For Treatment Naïve CLL Patients
Industry Brief - Jazz' Erwinaze IV Gains FDA Approval For ALL
Industry Brief - Poteligio Approved In Japan For Chemotherapy-Native CCR4-positive ATL
Industry Trend Analysis - Return Of Failed Drugs Will Bolster Pfizer's Haematology Pipeline
Industry Trend Analysis - Small Biotechs To Benefit From Rise In Epigenetic Treatments
Industry Trend Analysis - Immunotherapy Trends Highlighted At ASH Annual Meeting 2014
Industry Trend Analysis - Myelofibrosis Market Has Room For Growth
Industry Trend Analysis - Celgene Upholds Leading Position In Haematology At ASH 2014
Industry Brief - OncoGenex To Regain Rights To Custirsen From Teva
Industry Trend Analysis - Lynparza's Approval Will Benefit Myriad's Diagnostic Offerings
Industry Brief - Chugai Seeks Japanese Approval For Additional Indication Of Xeloda
Industry Brief - FDA Grants ODD To Nuvilex' PC Treatment
Industry Brief - NICE Issues Negative Decision For Abraxane In MPC
Industry Brief - Ignyta Gains Orphan Drug/Rare Paediatric Disease Designations For Entrectinib
Industry Brief - Zelboraf/cobas 4800 BRAF V600 Mutation Test Gain Japanese Approval
Industry Brief - VB-111 Moves To Phase III In Thyroid Cancer
Industry Brief - Medivation Exercises Licence Option For Pidilizumab From CureTech
Industry Brief - Torrent And Reliance Life Sciences Enter India Biosimilars Agreement
Industry Brief - FDA Approves Teva's Filgrastim For Self-Administration
Industry Brief - RedHill's Bekinda MAA Accepted For Review
Industry Brief - 3-V Completes Series D Fundraising
Industry Brief - Aduro Raises Funds To Advance Development Of Immuno-Oncology Pipeline
Industry Brief - Cancer Conferences - April 2015

Table Of Contents

Cancer Drug News 05 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.